Impact of Anti-DDT Campaigns on Malaria Control

Donald Roberts | 24 Feb 2010 | Outlooks on Pest Management

Public health insecticides have greatly improved human welfare. In the past century, insecticides were deployed strategically to control numerous human plagues, but successes in those endeavours brought new and unforeseen challenges.

Malaria indicator survey 2007, Ethiopia: coverage and use of major malaria prevention and control interventions

Daddi Jima et al | 24 Feb 2010 | Malaria Journal

Since mid-2005, the Ethiopian National Malaria Control Programme has considerably scaled-up its malaria prevention and control interventions, demonstrating the impact of strong political will and a committed partnership.

Expiry of medicines in supply outlets in Uganda

Josephine Katabaazi Nakyanzi et al | 12 Feb 2010 | World Health Organization

The expiry of medicines in the supply chain is a serious threat to the already constrained access to medicines in developing countries. We investigated the extent of, and the main contributing factors to, expiry of medicines in medicine supply outlets in Kampala and Entebbe, Uganda.

Retail sector distribution chains for malaria treatment in the developing world: a review of the literature

Edith Patouillard et al | 11 Feb 2010 | Malaria Journal

In many low-income countries, the retail sector plays an important role in the treatment of malaria and is increasingly being considered as a channel for improving medicine availability.

Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial

Quique Bassat et al | 17 Nov 2009 | PLoS One

Artemisinin combination therapies (ACTs) are currently the preferred option for treating uncomplicated malaria. Dihydroartemisinin-piperaquine (DHA-PQP) is a promising fixed-dose ACT with limited information on its safety and efficacy in African children.

Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets

Jane Chuma et al | 28 Oct 2009 | Malaria Journal

Effective case management is central to reducing malaria mortality and morbidity worldwide, but only a minority of those affected by malaria, have access to prompt effective treatment.

Assessing the Impact of Indoor Residual Spraying on Malaria Morbidity Using a Sentinel Site Surveillance System in Western Uganda

Hasifa Bukirwa et al | 13 Oct 2009 | American Journal of Tropical Medicine and Hygiene

A single round of indoor residual spraying (IRS) using lambda-cyhalothrin was implemented in a district of Uganda with moderate transmission intensity in 2007. Individual patient data were collected from one health facility within the district 8 months before and 16 months after IRS.

Ongoing challenges in the management of malaria

Gilbert Kokwaro | 12 Oct 2009 | Malaria Journal

This article gives an overview of some of the ongoing challenges that are faced in the prevention, diagnosis and treatment of malaria.

Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa

Karen Barnes, Pascalina Chanda & Gebre Ab Barnabas | 12 Oct 2009 | Malaria Journal

Malaria is one of the most significant causes of morbidity and mortality worldwide. Every year, nearly one million deaths result from malaria infection.

Simple Field Assays to Check Quality of Current Artemisinin-Based Antimalarial Combination Formulations

Jean-Robert Ioset et al | 30 Sep 2009 | PLoS One

Malaria continues to be one of the major public health problems in Africa, Asia and Latin America. Artemisinin derivatives (ARTs; artesunate, artemether, and dihydroartemisinin) derived from the herb, Artemisia annua, are the most effective antimalarial drugs available providing rapid cures.